as a deeper depletion of autoreactive MBCs could be established by adding B-cell-depleting therapy after the initiation of BLM. References: [1]Arends EJ et al. Long-term effects of combined B cell ...

An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according ...

Monoclonal B-cell lymphocytosis is when your body produces an elevated number of identical B cells. In some cases, it can develop into chronic lymphocytic leukemia. Monoclonal B-cell lymphocytosis ...

The potentially first-in-class drug, which targets CD20, is able to achieve "deep B-cell depletion" by stimulating cells of the immune system to engulf and destroy B-cells in the presence of a ...

Researchers found that cells from people with Werner syndrome (WS) have low NAD+ levels in mitochondria, leading to premature aging. Supplementing with nicotinamide riboside (NR), an NAD+ precursor, ...

The US regulator has approved Aucatzyl (obecabtagene autoleucel or obe-cel) for the treatment of adults with relapsed or refractory B-cell precursor ALL based on the results of the phase 2 FELIX ...

The Reedsburg Area Senior Life Center (RASLC) received a deficiency-free health survey for the fourth consecutive year. The facility was awarded a five-star rating by the United States Centers for ...

However, targeted paramagnetic particles provide a powerful strategy for localized heating of cancerous cells.